Skip to main content

Table 2 Clinic outcome scores: change from baseline during rTMS treatment for overall study population

From: Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study

 BaselineDay 5Day 30Day 60Day 90
PSQIa9.24 (3.89)5.09 (3.33)5 (3.13)5.28 (3.47)6.12 (3.32)
Change from Baseline −4.15 (0.53) *−4.24 (0.58) *−3.96 (0.67) *−3.12 (0.66) *
CCQb12.67 (10.93)2.21 (3.29)1.34 (2.79)1.84 (4)3.8 (6.5)
Change from Baseline −10.45 (1.15) *−11.32 (1.20) *− 10.81 (1.41) *−8.86 (1.38) *
BDI-IIc18.99 (9.91)-§5.09 (6.45)5.33 (7.67)6.72 (7.2)
Change from Baseline  −13.89 (1.38) *−13.65 (1.64) *− 12.26 (1.58) *
SASd47.93 (10.01)36.11 (8.45)35.97 (9.44)35.33 (9.52)38.09 (7.38)
Change from Baseline −11.81 (2.04) *−11.96 (1.54) *−12.60 (1.87) *−9.83 (1.77) *
GSIe65.91 (16.53)46.69 (12.17)47.67 (14.46)44.49 (10.92)46.46 (9.56)
Change from Baseline −19.22 (2.08) *−18.24 (2.25) *−21.42 (2.67) *−19.45 (2.59) *
  1. Data are presented as Mean (SD);
  2. * p value <.001; § BDI-II was not administered at day 5 because it refers to the last 2 weeks;
  3. a Pittsburgh Sleep Quality Inventory – general sleep quality index; b Cocaine Craving Questionnaire; c Beck Depression Inventory – II; d Self-rating Anxiety Scale;
  4. e Global Severity Index from Symptoms Checklist – 90 – Revised